Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up

BACKGROUND: Immunosuppressive therapy after life-saving kidney transplantation increases the risk of infection, cardiovascular diseases, metabolic diseases, and cancer. To date, four centers (three in the USA and one in South Korea) have reported clinical tolerance trials in kidney transplantation....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Wang, Xuanchuan, Yang, Cheng, Hu, Linkun, Wei, Zheng, Tang, Qunye, Chen, Bing, Ji, Yuan, Xu, Ming, Zeng, Zhaochong, Rong, Ruiming, Zhu, Tongyu
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7723571/
https://ncbi.nlm.nih.gov/pubmed/33313123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-2502a
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares